Ok-Ju Kang

Ulsan College

Papers

1

Total Citations

8

H-Index

1

About

Dr. Ok-Ju Kang is a leading figure in gynecologic oncology, with a primary research focus on advancing minimally invasive surgical techniques for the treatment of early-stage gynecologic cancers. Her most impactful work centers on evaluating the feasibility and safety of novel surgical platforms, most notably the ArtiSential system. As the principal investigator of the landmark KGOG 4002/GYANT study, a prospective, multi-institutional trial across 10 tertiary hospitals in Korea, Dr. Kang demonstrated that this articulating instrument can be safely and effectively employed for complex procedures. This pivotal 2024 study, already garnering 8 citations, provides critical evidence for expanding surgical options and improving patient outcomes. By rigorously assessing new technologies, Dr. Kang is directly shaping the future standard of care, offering patients less invasive paths to recovery. Her work stands as a testament to the power of collaborative clinical research in driving surgical innovation within gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility and Safety of ArtiSential for Minimally Invasive Surgery in Early-stage Gynecologic Cancer: Results from the KGOG 4002/GYANT Study
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Ulsan College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago